PT90308A - Processo para a preparacao de composicoes farmaceuticas contendo azelastina com libertacao controlada da substancia activa - Google Patents
Processo para a preparacao de composicoes farmaceuticas contendo azelastina com libertacao controlada da substancia activaInfo
- Publication number
- PT90308A PT90308A PT90308A PT9030889A PT90308A PT 90308 A PT90308 A PT 90308A PT 90308 A PT90308 A PT 90308A PT 9030889 A PT9030889 A PT 9030889A PT 90308 A PT90308 A PT 90308A
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical compositions
- active substance
- controlled
- libertacaous
- azelastin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3813244 | 1988-04-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT90308A true PT90308A (pt) | 1989-11-10 |
| PT90308B PT90308B (pt) | 1994-10-31 |
Family
ID=6352451
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT90308A PT90308B (pt) | 1988-04-20 | 1989-04-19 | Processo para a preparacao de composicoes farmaceuticas contendo azelastina com libertacao controlada da substancia activa |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0338444B1 (pt) |
| JP (1) | JP2950845B2 (pt) |
| AT (1) | ATE97572T1 (pt) |
| AU (1) | AU3318389A (pt) |
| CA (1) | CA1325976C (pt) |
| DE (1) | DE58906232D1 (pt) |
| DK (1) | DK172235B1 (pt) |
| ES (1) | ES2060685T3 (pt) |
| FI (1) | FI891865A (pt) |
| HK (1) | HK134494A (pt) |
| HU (1) | HU202403B (pt) |
| IE (1) | IE62778B1 (pt) |
| MC (1) | MC2025A1 (pt) |
| PT (1) | PT90308B (pt) |
| ZA (1) | ZA892877B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9003903D0 (sv) * | 1990-12-07 | 1990-12-07 | Astra Ab | New pharmaceutical formulations |
| DE4207234A1 (de) * | 1992-03-07 | 1993-09-09 | Asta Medica Ag | Neue aminocarbonsaeure-derivate mit antiallergischer/antiasthmatischer wirkung und verfahren zu deren herstellung |
| JPH0710747A (ja) * | 1993-04-28 | 1995-01-13 | Takeda Chem Ind Ltd | 固形製剤およびその製造方法 |
| GB9514842D0 (en) * | 1995-07-20 | 1995-09-20 | Smithkline Beecham Plc | Novel formulation |
| JP4138910B2 (ja) | 1997-07-02 | 2008-08-27 | 帝國製薬株式会社 | 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤 |
| UA67802C2 (uk) * | 1998-10-23 | 2004-07-15 | Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. | Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції |
| DK1126826T6 (en) | 1998-11-02 | 2019-06-24 | Alkermes Pharma Ireland Ltd | Multiparticulate modified release of methylphenidate |
| NZ529928A (en) | 1999-10-29 | 2005-10-28 | Euro Celtique Sa | Controlled release hydrocodone formulations |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| KR101045144B1 (ko) | 2000-10-30 | 2011-06-30 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
| EP1396263A1 (en) * | 2002-08-09 | 2004-03-10 | Warner-Lambert Company | Film coating for tablets and caplets |
| CA2510320C (en) | 2002-12-20 | 2012-10-09 | St. James Associates Llc/Faber Research Series | Coated particles for sustained-release pharmaceutical administration |
| PT2522365T (pt) * | 2004-11-24 | 2017-02-08 | Meda Pharmaceuticals Inc | Composições que compreendem azelastina e seus métodos de utilização |
| US9987233B2 (en) | 2013-03-21 | 2018-06-05 | Eupraxia Pharmaceuticals USA LLC | Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith |
| EP3206672B1 (en) | 2015-10-27 | 2018-03-14 | Eupraxia Pharmaceuticals Inc. | Sustained release formulations of local anesthetics |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3575135D1 (de) * | 1984-09-14 | 1990-02-08 | Asta Pharma Ag | Substituierte benzylphthalazinon-derivate. |
-
1989
- 1989-04-11 MC MC892044A patent/MC2025A1/xx unknown
- 1989-04-14 AT AT89106685T patent/ATE97572T1/de not_active IP Right Cessation
- 1989-04-14 EP EP89106685A patent/EP0338444B1/de not_active Expired - Lifetime
- 1989-04-14 DE DE89106685T patent/DE58906232D1/de not_active Expired - Lifetime
- 1989-04-14 ES ES89106685T patent/ES2060685T3/es not_active Expired - Lifetime
- 1989-04-19 IE IE126389A patent/IE62778B1/en not_active IP Right Cessation
- 1989-04-19 CA CA000597169A patent/CA1325976C/en not_active Expired - Lifetime
- 1989-04-19 HU HU891912A patent/HU202403B/hu not_active IP Right Cessation
- 1989-04-19 ZA ZA892877A patent/ZA892877B/xx unknown
- 1989-04-19 FI FI891865A patent/FI891865A/fi not_active Application Discontinuation
- 1989-04-19 DK DK189189A patent/DK172235B1/da not_active IP Right Cessation
- 1989-04-19 PT PT90308A patent/PT90308B/pt not_active IP Right Cessation
- 1989-04-19 AU AU33183/89A patent/AU3318389A/en not_active Abandoned
- 1989-04-20 JP JP1099031A patent/JP2950845B2/ja not_active Expired - Lifetime
-
1994
- 1994-12-01 HK HK134494A patent/HK134494A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK189189A (da) | 1989-10-21 |
| DK172235B1 (da) | 1998-02-02 |
| ZA892877B (en) | 1989-12-27 |
| CA1325976C (en) | 1994-01-11 |
| ES2060685T3 (es) | 1994-12-01 |
| IE62778B1 (en) | 1995-02-22 |
| AU3318389A (en) | 1989-10-26 |
| HK134494A (en) | 1994-12-09 |
| DK189189D0 (da) | 1989-04-19 |
| ATE97572T1 (de) | 1993-12-15 |
| HU202403B (en) | 1991-03-28 |
| IE891263L (en) | 1989-10-20 |
| MC2025A1 (fr) | 1990-04-25 |
| DE58906232D1 (de) | 1994-01-05 |
| FI891865A0 (fi) | 1989-04-19 |
| PT90308B (pt) | 1994-10-31 |
| JPH01311024A (ja) | 1989-12-15 |
| EP0338444B1 (de) | 1993-11-24 |
| JP2950845B2 (ja) | 1999-09-20 |
| EP0338444A1 (de) | 1989-10-25 |
| FI891865A (fi) | 1989-10-21 |
| HUT49808A (en) | 1989-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY105121A (en) | Pharmaceutical composition for systemic transdermal administration. | |
| IL95691A0 (en) | Thienylcarboxylates of amino alcohols,their preparation and pharmaceutical compositions containing them | |
| PT90308A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo azelastina com libertacao controlada da substancia activa | |
| GR3007202T3 (pt) | ||
| DK0430045T3 (da) | Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion | |
| ATE76747T1 (de) | Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen. | |
| BR9401199A (pt) | Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento. | |
| DK0395329T4 (da) | Sammensætning i form af et skum indeholdende 5-aminosalicylsyre til intrarektal administration | |
| ES2115638T3 (es) | Composicion tiroactiva de liberacion controlada. | |
| ATE108657T1 (de) | Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus. | |
| DE3766200D1 (de) | L-dopa enthaltendes arzneimittel. | |
| GR3026218T3 (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha D-neuraminic acid | |
| ATE75945T1 (de) | Pharmazeutische zubereitung zur behandlung des diabetes mellitus. | |
| ES2084579T3 (es) | Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol. | |
| ES2052028T3 (es) | Un metodo para preparar compuestos diarilicos anti-ateroscleroticos. | |
| HUT57204A (en) | Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them | |
| EP0316639A3 (en) | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient | |
| ES512748A0 (es) | "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina". | |
| DE68900693D1 (de) | Pharmazeutische praeparate zur transdermalen applikation von heparin. | |
| DE69000259T2 (de) | Pharmazeutische zusammensetzung enthaltend 1-isopropyldihydrolysergsaeure. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG3A | Patent granted, date of granting |
Effective date: 19940411 |
|
| PC3A | Transfer or assignment |
Free format text: ASTA MEDICA HEALTH PRODUCTS GMBH & CO. KG DE Effective date: 20020909 |
|
| PD3A | Change of proprietorship |
Free format text: VIATRIS GMBH & CO. KG DE Effective date: 20020909 Free format text: ASTA MEDICA GMBH DE Effective date: 20020909 |
|
| TE3A | Change of address (patent) |
Free format text: ASTA MEDICA AKTIENGESELLSCHAFT DE Effective date: 20020909 |
|
| TE3A | Change of address (patent) |
Free format text: VIATRIS GMBH & CO. KG DE Effective date: 20050506 |
|
| PD4A | Change of proprietorship |
Owner name: MEDA PHARMA GMBH & CO. KG, DE Effective date: 20070604 |
|
| MM4A | Annulment/lapse due to non-payment of fees, searched and examined patent |
Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20090419 |